EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Survival following sublobar resection after neoadjuvant therapy for T1N1-2M0 lung cancer

Hayley Reddington, Isabel Emmerick iD, Javier Diaz Collante iD, Aniket Maini, Raghav Kanzaria, Allison Crawford, William Phillips, Mark Maxfield, Karl Uy, Feiran Lou iD

PLOS One · 03.06.2026 · 21 (6) · e0349231

DOI: 10.1371/journal.pone.0349231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 03.06.2026. Verfasst von Hayley Reddington und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Thoracic Surgery, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of Amer…. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Lung Neoplasms, Pneumonectomy, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lobectomy remains the standard surgical approach for resectable non-small cell lung cancer (NSCLC), but sublobar resection is increasingly considered, particularly for small, early-stage tumors. The role of sublobar resection after neoadjuvant therapy is unclear. We compared survival after sublobar resection versus lobectomy among patients with T1N1-2M0 NSCLC treated with neoadjuvant therapy.

Methods

Using the National Cancer Database (2011–2021), we identified patients ≥18 years with clinical stage T1N1-2M0 NSCLC who received neoadjuvant chemotherapy, chemoradiation, or chemoimmunotherapy followed by resection within 8 months. Patients with pneumonectomy, metastases, positive margins were excluded. Patients were grouped by resection type: sublobar (wedge or segmentectomy) vs. lobectomy (including bilobectomy and extended). Survival was assessed via Kaplan–Meier analysis and multivariable Cox regression.

Results

Of 2,257 patients, 148 (6.6%) underwent sublobar resection. Compared to lobectomy, sublobar resection was associated with fewer lymph nodes examined (24% vs. 54% with >10 nodes, p < 0.001) and shorter hospital stays (3.9 vs. 5.3 days, p < 0.001). Stage distribution was similar. One-year survival was comparable for both groups in stage II and III disease. At 5 years, survival was lower for stage III patients undergoing sublobar resection (48.6% vs. 59.9%, p < 0.01), with adjusted analysis confirming worse survival (HR = 1.41, p = 0.013).

Conclusions

Among patients with T1N1-2M0 NSCLC treated with neoadjuvant therapy, sublobar resection was associated with similar short-term but inferior long-term survival compared to lobectomy. Lobectomy remains preferred for patients with adequate reserve, though sublobar resection may be appropriate for select patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyLung NeoplasmsPneumonectomyCarcinoma, Non-Small-Cell LungHumansFemaleMaleMiddle AgedAgedNeoplasm StagingKaplan-Meier Estimate

Autor:innen und Institutionen

  • Department of Surgery, Division of Thoracic Surgery, University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.
  • University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.

ORCID-Profile: Isabel Emmerick, Javier Diaz Collante, Feiran Lou

Zitieren

APA

Reddington, H., Emmerick, I., Diaz Collante, J., Maini, A., Kanzaria, R., Crawford, A., Phillips, W., Maxfield, M., Uy, K., & Lou, F. (2026). Survival following sublobar resection after neoadjuvant therapy for T1N1-2M0 lung cancer. PLOS One, 21(6), e0349231. https://doi.org/10.1371/journal.pone.0349231

Vancouver

Reddington H, Emmerick I, Diaz Collante J, Maini A, Kanzaria R, Crawford A, et al. Survival following sublobar resection after neoadjuvant therapy for T1N1-2M0 lung cancer. PLOS One. 2026;21(6):e0349231. doi:10.1371/journal.pone.0349231

BibTeX
@article{Reddington2026,
  author = {Reddington, Hayley and Emmerick, Isabel and Diaz Collante, Javier and Maini, Aniket and Kanzaria, Raghav and Crawford, Allison and Phillips, William and Maxfield, Mark and Uy, Karl and Lou, Feiran},
  title = {Survival following sublobar resection after neoadjuvant therapy for T1N1-2M0 lung cancer},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {e0349231},
  doi = {10.1371/journal.pone.0349231}
}
Kostenlos starten →